Syneos health, inc. (SYNH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities:
Net income (loss)

194,836

131,258

85,878

16,564

18,832

24,284

-36,433

-174,037

-184,208

-138,469

-85,931

89,398

116,412

112,630

105,795

116,278

109,196

117,047

36,611

11,352

3,338

-23,470

0

0

0

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization

237,372

242,465

252,214

260,111

266,864

273,685

286,905

284,303

232,329

179,936

112,147

61,484

60,479

59,204

57,703

56,753

56,123

56,014

56,534

57,046

54,416

54,543

0

0

0

Amortization of Senior Notes premium, net of capitalized loan fees and original issue discount

-

-

-

-

-

-

-

-

0

-

0

0

911

-

1,032

1,058

1,167

1,346

1,961

2,668

3,197

5,700

0

0

0

Share-based compensation

56,924

55,193

49,142

46,130

40,711

34,323

34,813

63,902

61,756

59,696

55,544

20,181

17,023

14,020

11,190

9,341

7,183

5,074

4,353

3,566

3,546

3,370

0

0

0

Provision for doubtful accounts

866

1,897

-186

-2,070

-3,456

-4,587

-763

2,275

4,345

4,167

2,120

1,630

1,434

2,570

2,223

1,099

774

-144

-816

754

2,080

2,435

0

0

0

Provision for deferred income taxes

-33,454

-40,069

14,052

16,715

12,519

240

977

15,830

3,609

14,431

-4,301

-26,010

-20,905

-22,260

-1,204

-914

1,927

4,134

7,508

7,322

-14,411

-14,837

0

0

0

Foreign currency transaction gains

3,776

-11,166

7,328

-2,511

22,606

16,165

13,279

17,603

-11,569

-7,912

-8,156

-12,970

-15,614

-20,681

-20,296

-17,261

-9,368

795

-1,005

6,912

7,451

7,390

0

0

0

Asset impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,931

3,931

3,931

21,176

17,245

0

0

0

Fair value adjustment of contingent obligations

12,441

17,260

-15,743

-14,918

-12,060

-11,590

-8,694

-9,888

-11,082

-12,276

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

14,750

10,395

-4,594

-6,383

-8,260

-4,153

-4,434

-2,747

-870

-622

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash items

-4,513

-2,766

-857

28

-410

-2,849

-6,977

-8,536

-6,644

-5,212

-2,502

-1,821

-1,492

-1,258

-230

-218

-164

82

1,393

1,247

978

853

0

0

0

Changes in operating assets and liabilities:
Accounts receivable, unbilled services, and deferred revenue

147,996

120,389

158,902

118,527

32,475

97,621

27,797

39,874

77,490

-60,623

1,322

6,758

-8,641

99,688

28,714

86,327

86,905

54,073

96,993

18,922

64,436

24,259

0

0

0

Accounts payable and accrued expenses

-11,428

28,316

66,990

95,298

47,583

60,024

-1,479

-28,945

-10,766

-16,982

-2,580

11,282

-26,847

6,658

9,377

22,467

35,312

8,186

5,112

-1,438

22,370

25,743

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19,500

22,475

27,639

68,500

85,157

33,031

70,603

42,742

0

0

0

Other assets and liabilities

2,368

987

21,187

-13,619

-12,511

-33,853

-34,610

-28,162

-8,233

-3,386

-13,434

-3,146

-11,056

-13,978

-135

6,011

11,942

14,855

7,673

4,366

-1,191

-1,251

0

0

0

Net cash used in operating activities

293,180

318,481

270,381

321,788

337,127

303,448

279,512

165,006

75,574

198,258

124,112

163,540

185,835

109,490

158,742

153,841

160,463

204,740

155,241

146,326

143,868

131,447

0

0

0

Cash flows from investing activities:
Payments associated with business combinations, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,302

0

0

0

Purchases of property and equipment

64,398

63,973

62,277

50,075

44,754

54,595

58,706

60,508

54,611

43,896

42,680

35,837

37,150

31,353

26,372

24,932

21,015

21,111

19,377

20,281

25,797

25,551

0

0

0

Investments in unconsolidated affiliates

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-88,836

-81,661

-71,504

-143,965

-135,644

-145,485

-150,270

-1,739,456

-1,733,559

-1,722,844

-1,720,954

-35,837

-37,150

-31,353

-26,372

-24,932

-21,015

-21,111

-19,377

-20,281

-25,797

-27,853

0

0

0

Cash flows from financing activities:
Proceeds from issuance of long-term debt, net of discount

398,805

582,000

183,195

183,195

183,195

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of debt financing costs

2,452

2,636

2,593

673

3,246

3,062

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of long-term debt

221,800

437,936

407,186

549,282

575,532

390,646

404,396

622,597

556,347

525,097

0

0

0

-

-

-

-

475,001

633,643

633,643

159,705

164,095

0

0

0

Proceeds from accounts receivable financing agreement

107,915

127,815

132,100

225,900

214,200

187,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of accounts receivable financing agreement

29,000

22,400

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from revolving line of credit

0

-

-

-

0

-

-

-

-

15,000

15,000

100,000

115,000

100,000

0

0

0

-

-

-

-

-

-

-

-

Repayments of revolving line of credit

-

-

-

-

-

-

-

-

-

40,000

40,000

100,000

100,000

105,000

120,000

60,000

45,000

15,000

0

0

0

-

-

-

-

Payments of contingent consideration related to business combinations

26,762

178

23,280

23,110

23,110

23,102

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of finance leases

17,893

14,493

12,188

11,237

12,218

15,423

17,223

17,008

12,624

8,145

0

0

0

-

-

-

-

452

623

1,408

2,066

2,680

0

0

0

Payments for repurchases of common stock

62,129

56,716

56,716

49,671

64,108

74,985

74,985

74,985

37,493

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercises of stock options

32,956

40,322

43,454

38,740

35,877

21,821

20,329

20,542

19,850

19,335

20,524

15,017

19,485

17,891

17,013

12,781

7,215

3,656

0

0

0

-

-

-

-

Payments related to tax withholdings for share-based compensation

20,741

13,135

12,650

12,739

12,575

3,359

4,645

8,028

7,974

6,824

5,405

1,981

2,001

839

858

2,587

3,205

3,194

0

0

0

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

375

0

0

0

Net cash provided by (used in) financing activities

40,787

-215,469

-196,564

-239,577

-275,817

-319,356

-302,557

1,574,602

1,670,511

1,734,368

1,793,710

-52,332

-32,884

-53,316

-158,793

-124,918

-236,589

-211,399

-168,869

-167,768

-62,569

-67,698

0

0

0

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-17,092

-13,594

-7,713

-4,709

-6,700

-4,651

2,391

3,277

11,389

9,116

5,260

2,551

-4,394

-7,206

-6,720

-10,586

-6,027

-13,672

-16,707

-15,315

-13,312

-6,415

0

0

0

Net change in cash, cash equivalents, and restricted cash

228,039

7,757

-5,400

-66,463

-81,034

-166,044

-170,924

3,429

23,915

218,898

202,128

77,922

111,407

17,615

-33,143

-6,595

-103,168

-41,442

-49,712

-57,038

42,190

29,481

0

0

0

Supplemental disclosures of non-cash investing activities:
Purchases of property and equipment included in liabilities

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Vehicles acquired through capital lease agreements

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-